HUP9900375A3 - Transdermal matrix system, its use and process for producing the same - Google Patents

Transdermal matrix system, its use and process for producing the same

Info

Publication number
HUP9900375A3
HUP9900375A3 HU9900375A HUP9900375A HUP9900375A3 HU P9900375 A3 HUP9900375 A3 HU P9900375A3 HU 9900375 A HU9900375 A HU 9900375A HU P9900375 A HUP9900375 A HU P9900375A HU P9900375 A3 HUP9900375 A3 HU P9900375A3
Authority
HU
Hungary
Prior art keywords
producing
same
matrix system
transdermal matrix
transdermal
Prior art date
Application number
HU9900375A
Other languages
English (en)
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of HUP9900375A2 publication Critical patent/HUP9900375A2/hu
Publication of HUP9900375A3 publication Critical patent/HUP9900375A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Telephonic Communication Services (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Steroid Compounds (AREA)
HU9900375A 1995-09-27 1996-09-25 Transdermal matrix system, its use and process for producing the same HUP9900375A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511326A FR2739032B1 (fr) 1995-09-27 1995-09-27 Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique

Publications (2)

Publication Number Publication Date
HUP9900375A2 HUP9900375A2 (hu) 1999-06-28
HUP9900375A3 true HUP9900375A3 (en) 1999-11-29

Family

ID=9482961

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900375A HUP9900375A3 (en) 1995-09-27 1996-09-25 Transdermal matrix system, its use and process for producing the same

Country Status (25)

Country Link
US (1) US6013276A (hu)
EP (1) EP0852492B1 (hu)
JP (1) JPH11514988A (hu)
KR (1) KR19990063732A (hu)
CN (1) CN1083259C (hu)
AT (1) ATE209031T1 (hu)
AU (1) AU702542B2 (hu)
BG (1) BG102322A (hu)
BR (1) BR9610665A (hu)
CA (1) CA2233162A1 (hu)
CZ (1) CZ95398A3 (hu)
DE (1) DE69617252T2 (hu)
DK (1) DK0852492T3 (hu)
EE (1) EE9800082A (hu)
ES (1) ES2170266T3 (hu)
FR (1) FR2739032B1 (hu)
HU (1) HUP9900375A3 (hu)
IL (1) IL123594A0 (hu)
NO (1) NO981252D0 (hu)
NZ (1) NZ319181A (hu)
PL (1) PL325644A1 (hu)
PT (1) PT852492E (hu)
SK (1) SK282613B6 (hu)
TR (1) TR199800563T1 (hu)
WO (1) WO1997011687A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049628C2 (de) * 1980-12-31 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5286490A (en) * 1990-05-04 1994-02-15 Colgate-Palmolive Company Transdermal fluoride medication
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
AU702542B2 (en) 1999-02-25
DE69617252T2 (de) 2002-07-25
CA2233162A1 (en) 1997-04-03
MX9802327A (es) 1998-08-30
PL325644A1 (en) 1998-08-03
AU7134996A (en) 1997-04-17
NO981252L (no) 1998-03-19
ES2170266T3 (es) 2002-08-01
CN1083259C (zh) 2002-04-24
IL123594A0 (en) 1998-10-30
NZ319181A (en) 1998-10-28
DE69617252D1 (de) 2002-01-03
EP0852492B1 (fr) 2001-11-21
WO1997011687A1 (fr) 1997-04-03
BR9610665A (pt) 1999-07-13
FR2739032A1 (fr) 1997-03-28
EE9800082A (et) 1998-10-15
BG102322A (en) 1998-10-30
SK40698A3 (en) 1998-09-09
CN1197390A (zh) 1998-10-28
KR19990063732A (ko) 1999-07-26
ATE209031T1 (de) 2001-12-15
JPH11514988A (ja) 1999-12-21
NO981252D0 (no) 1998-03-19
HUP9900375A2 (hu) 1999-06-28
SK282613B6 (sk) 2002-10-08
PT852492E (pt) 2002-05-31
CZ95398A3 (cs) 1998-07-15
US6013276A (en) 2000-01-11
FR2739032B1 (fr) 1997-11-21
DK0852492T3 (da) 2002-05-13
TR199800563T1 (xx) 1998-06-22
EP0852492A1 (fr) 1998-07-15

Similar Documents

Publication Publication Date Title
HUP9802337A3 (en) Process for activating polysaccharides, polysaccharides produced by this process, and use thereof
HUP9600647A3 (en) Phosphono-monoester-nucleinic acids, process for producing them, and their use
AU7135196A (en) Transdermal matrix system
AU7489596A (en) Reinforced formed part, process for its production and its use
HUP9902673A3 (en) Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
HUP9900375A3 (en) Transdermal matrix system, its use and process for producing the same
EP0761279A3 (en) Honeycomb body, its manufacturing process, its use and heater
EP0578498A3 (en) Acrylic polymer, its use and process for producing it
EP0785205A4 (en) 2-SILYLOXYTETRAHYDROTHIENOPYRIDINE, ITS SALT, AND ITS PRODUCTION METHOD
EP0725137A4 (en) KETO GROUP INTRODUCTIVE ENZYME, ENCODING DNA, AND METHOD FOR PRODUCING KETOCAROTENOID
HU9403137D0 (en) Polymer system, process for producing said polymer system and using said polymer system
AU5123996A (en) Bactericidal mat, process for producing the same, and use thereof
EP0852242A4 (en) POLYCARBONATE AND PROCESS FOR THE PRODUCTION THEREOF
AU5721996A (en) Catalyst and process for preparing same
HU9700566D0 (en) Amino-alkyl- and acyl-amino-alkyl-ethers, process for producing them and their use as bradiquinine-receptor-antagonists
EP0693474A4 (en) NEW BENZYLAMINOETHOXYBENZENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
EP0622369A3 (de) 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung.
ZA966757B (en) Novel compounds and process.
HU9603108D0 (en) Matrix system for the transdermal delivery of ibuprofen, and method for preparing same
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
AU4448296A (en) Metal matrix composite and process for producing the same
ZA966661B (en) Catalyst, use thereof and preparation process.
EP0775705A3 (en) Cyclopentenecarboxamide derivative, method for its preparation and bicycloamide derivative used in this method
ZA961986B (en) Phosponomonoester nucleic acids, process for their preparation, and their use